Newsroom
Institut de Reserches Servier contracts Pangaea to provide biomarker discovery services
Barcelona, March 13th - Pangaea Oncology and Institut de Reserches Servier have signed a contract for Pangaea to provide biomarker discovery (drug profiling) services to Servier through 2017. Institut de Reserches Servier belongs to the French pharmaceutical multinational Servier, which has contracted Pangaea’s services since 2014 in the areas of patients recruitment for clinical trials, through the Dr. Rosell Oncology Institute, as a central laboratory for molecular diagnostics, and for biomarker discovery (drug profiling) services.
Follow us
